Sandoz Group AG (SDZNY OTCGREY) stock market data APIs
$80.9069
-0.29(-0.4%)
as of September 10, 2026
Try our APIs with
free plan!
Sandoz Group AG Financial Data Overview
Price chart is built with
Anychart
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Prev. Close
80.9069
Open
80.6122
High
80.9116
Low
80.4814
52 wk Range
54.7495-93.35
Market Cap
35 173 M
P/E Ratio
56.6993
Shares Outstanding
433 M
Revenue
11 676 M
Dividends (Yield)
0.0123
Beta
0.491
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sandoz Group AG (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sandoz Group AG data using free add-ons & libraries
Get Sandoz Group AG Fundamental Data
Sandoz Group AG Fundamental data includes:
- Net Revenue: 11 676 M
- EBITDA: 1 574 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sandoz Group AG News
New
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking ...
Switzerland's Sandoz aims to double sales by 2035 in expanded biosimilars push
[The company sign of Sandoz Switzerland AG - an international pharmaceutical company] * Swiss drug maker Sandoz (SDZNY [https://seekingalpha.com/symbol/SDZNY]) aims to more than double net sales fr...
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
For Immediate Release Chicago, IL – August 31, 2026 – Today, Zacks Equity Research discusses Amphastar Pharmaceuticals AMPH, Sandoz SDZNY and Viatris VTRS. Industry: Generic Drugs Link: https:/...
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Recent earnings across the generic drug industry point to a mixed but generally resilient operating environment. Reported sales at several manufacturers were affected by lower contributions from older...
Get Sandoz Group AG fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
